(Q31111852)

English

Characterization of xylazine metabolism in rat liver microsomes using liquid chromatography-hybrid triple quadrupole-linear ion trap-mass spectrometry

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Characterization of xylazine metabolism in rat liver microsomes using liquid chromatography-hybrid triple quadrupole-linear ion trap-mass spectrometry (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

1 reference

based on heuristic

inferred from title

author name string

David St-Germain Lavoie

1

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Floriane Pailleux

2

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Pascal Vachon

3

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Francis Beaudry

4

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

publication date

28 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Biomedical Chromatography

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

882-888

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons

1 reference

https://api.crossref.org/works/10.1002%2FBMC.2875

21 January 2018

Characterization of testosterone 11 beta-hydroxylation catalyzed by human liver microsomal cytochromes P450.

1 reference

https://api.crossref.org/works/10.1002%2FBMC.2875

21 January 2018

Quantitative high-throughput analysis of drugs in biological matrices by mass spectrometry.

1 reference

https://api.crossref.org/works/10.1002%2FBMC.2875

21 January 2018

Model for the drug-drug interaction responsible for CYP3A enzyme inhibition. II: establishment and evaluation of dexamethasone-pretreated female rats

1 reference

https://api.crossref.org/works/10.1002%2FBMC.2875

21 January 2018

CYP3A4 drug interactions: correlation of 10 in vitro probe substrates

1 reference

https://api.crossref.org/works/10.1002%2FBMC.2875

21 January 2018

Enantioselective capillary electrophoresis for the assessment of CYP3A4-mediated ketamine demethylation and inhibition in vitro

1 reference

https://api.crossref.org/works/10.1002%2FBMC.2875

21 January 2018

In vitro high throughput screening of compounds for favorable metabolic properties in drug discovery

1 reference

https://api.crossref.org/works/10.1002%2FBMC.2875

21 January 2018

Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans

1 reference

https://api.crossref.org/works/10.1002%2FBMC.2875

21 January 2018

Reported analgesic and anaesthetic administration to rodents undergoing experimental surgical procedures

1 reference

https://api.crossref.org/works/10.1002%2FBMC.2875

21 January 2018

Endotoxin from various gram-negative bacteria has differential effects on function of hepatic cytochrome P450 and drug transporters

1 reference

https://api.crossref.org/works/10.1002%2FBMC.2875

21 January 2018

Identifiers

10.1002/BMC.2875

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31111852&oldid=1633496546"